SSi Mantra robot surpasses 4,000 surgeries, zero complications; targeting CE mark late 2025, FDA H1 2026

SS Innovations International, Inc.

SSi Mantra system used in >4,000 surgeries across >100 types with no complications, injuries, or mortalities.
Milestone includes ~215 cardiac procedures, of which 6 were telesurgery across India using SSi Mantra 3.
System cleared for market in 7 countries: India, Nepal, Ecuador, Guatemala, Philippines, Indonesia, Ukraine.
Company expects CE Mark decision as soon as late 2025 and FDA decision as soon as first half 2026.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.